Simplex Trading’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.2K Buy
5,100
+3,800
+292% +$73.2K ﹤0.01% 5223
2025
Q4
$17.2K Sell
1,300
-146,000
-99% -$1.29M ﹤0.01% 6617
2025
Q3
$866K Buy
147,300
+10,600
+8% +$49.6K ﹤0.01% 3203
2025
Q2
$564K Buy
136,700
+15,800
+13% +$63.7K ﹤0.01% 3378
2025
Q1
$454K Buy
+120,900
New +$559K ﹤0.01% 3490

Other funds holding BIOA

Simplex Trading's BIOA Position: Q1 2026 in Review

Simplex Trading reduced its BioAge Labs (BIOA) stake by 19% in Q1 2026, selling an estimated $10.4K and leaving 2,322 shares worth $40.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6091.

Simplex Trading first reported a position in BIOA in Q1 2025 and has held it in 5 quarters since. The position peaked at $81K in Q1 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Simplex Trading held 2,322 shares of BioAge Labs worth $40.6K as of Q1 2026.
  • Simplex Trading sold 538 BioAge Labs shares in Q1 2026, an estimated $10.4K.
  • BioAge Labs made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6091 holding.
  • Simplex Trading first reported a position in BioAge Labs in Q1 2025 and has held it in 5 quarters since.
  • Simplex Trading's BioAge Labs position peaked at $81K in Q1 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.